Sarepta Therapeutics Inc (SRPT): Are Investors Missing The Big Picture?

Sarepta Therapeutics Inc (NASDAQ:SRPT) does about 1.26M shares in volume on a normal day but saw 1062683 shares change hands in Friday’s trading. The company now has a market cap of 11.66B USD. Its current market price is $123.32, marking an increase of 5.01% compared to the previous close of $117.44. The 52 week high reached by this stock is $146.68 whilst the lowest price level in 52 weeks is $55.25.

Sarepta Therapeutics Inc (SRPT) has a 20-day trading average at $126.00 and the current price is -15.93% off the 52-week high compared with 123.20% distance from its 52-week low. The 50-day simple moving average of the closing price is $125.95 and its 200-day simple moving average is $114.56. If we look at the stock’s price movements over the week, volatility stands at 4.71%, which decreases to 3.83% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 47.88 to suggest the stock is neutral.

The consensus objective for the share price is $165.90, suggesting that the stock has a potential upside of 25.67% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 31, 2024 when Piper Sandler initiated the stock to “Overweight” and issued a price target of $157. RBC Capital Mkts downgraded the stock to “Sector Perform” from Outperform on May 28, 2024 at a price target of $157-$142. Oppenheimer upgraded its price target at $180.

Sarepta Therapeutics Inc (SRPT) stock is down -5.04% over the week and -6.98% over the past month. Its price is 27.89% year-to-date and -3.58% over the past year.

To reach the target analysts have set, the stock logically needs to grow 25.67 percent from here.

The company has a return on investment of 0.76% and return on equity of 2.02%. The price to earnings ratio (P/E ratio) amounts to 1854.44 while the forward price to earnings ratio is 11.56. The beta has a value of 0.86. Price to book ratio is 12.12 and price to sales ratio is 8.31.